+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
From
From
From
From
From
From
From
PBF-680 Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

PBF-680 Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
From
From
From
From
Asthma - Pipeline Insight, 2026 - Product Thumbnail Image

Asthma - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 280 Pages
  • Global
From
NUCALA Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

NUCALA Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
Dupilumab Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

Dupilumab Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
Non-Cystic Fibrosis Bronchiectasis - Pipeline Insight, 2026 - Product Thumbnail Image

Non-Cystic Fibrosis Bronchiectasis - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 60 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2026 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
OFEV Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

OFEV Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
TEZSPIRE Sales Forecast and Market Size Analysis - - Product Thumbnail Image

TEZSPIRE Sales Forecast and Market Size Analysis -

  • Report
  • March 2026
  • 30 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more